Canandaigua National Trust Co of Florida Makes New Investment in Cigna Group $CI

Canandaigua National Trust Co of Florida purchased a new stake in shares of Cigna Group (NYSE:CI) in the third quarter, Holdings Channel reports. The firm purchased 3,269 shares of the health services provider’s stock, valued at approximately $889,000.

Several other institutional investors have also recently bought and sold shares of the business. Osbon Capital Management LLC bought a new position in shares of Cigna Group in the second quarter valued at $26,000. Cedar Mountain Advisors LLC increased its position in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter worth about $29,000. Fiduciary Financial Advisors acquired a new stake in shares of Cigna Group in the 2nd quarter worth about $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in Cigna Group in the 2nd quarter valued at about $34,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 22,730 shares of company stock valued at $6,293,359. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the subject of a number of analyst reports. Piper Sandler set a $370.00 price target on Cigna Group and gave the company an “overweight” rating in a research note on Friday, October 2nd. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Barclays raised their target price on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. UBS Group reiterated a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Finally, Guggenheim increased their price target on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $338.24.

Cigna Group Stock Performance

Shares of Cigna Group stock traded up $4.70 during mid-day trading on Wednesday, hitting $279.07. 1,632,875 shares of the stock were exchanged, compared to its average volume of 1,681,951. Cigna Group has a 12 month low of $239.51 and a 12 month high of $312.18. The company has a 50-day simple moving average of $277.85 and a 200 day simple moving average of $280.71. The company has a market capitalization of $73.74 billion, a P/E ratio of 11.55, a P/E/G ratio of 0.92 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts anticipate that Cigna Group will post 30.5 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.